# Escalade Inc: overview

ESCA · Nasdaq · CIK 33488 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esca.md) · [Financials](/companies/esca/financials.md) · [Filings](/companies/esca/filings.md) · [Insiders](/companies/esca/insiders.md)

Latest reported revenue: [$65.6m](/filings/0001437749-26-033847.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 29, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001437749-26-033847).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [63.9 d](/filings/0001437749-26-006094.md) | [55.5](/filings/0001437749-26-013975.md) | [54.3](/filings/0001437749-26-024943.md) | [67.8](/filings/0001437749-26-033847.md) | [62.6 d](/filings/0001437749-26-006094.md) | [55.8](/filings/0001437749-26-013975.md) | [57.7](/filings/0001437749-26-024943.md) | [65.6](/filings/0001437749-26-033847.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [7.1% d](/filings/0001437749-26-006094.md) | [6.6%](/filings/0001437749-26-013975.md) | [4.8%](/filings/0001437749-26-024943.md) | [10.8%](/filings/0001437749-26-033847.md) | [8.2% d](/filings/0001437749-26-006094.md) | [10.5%](/filings/0001437749-26-013975.md) | [20.7%](/filings/0001437749-26-024943.md) | [13.2%](/filings/0001437749-26-033847.md) |
| Net margin | % | [4.2% d](/filings/0001437749-26-006094.md) | [4.7%](/filings/0001437749-26-013975.md) | [3.4%](/filings/0001437749-26-024943.md) | [8.2%](/filings/0001437749-26-033847.md) | [5.9% d](/filings/0001437749-26-006094.md) | [7.9%](/filings/0001437749-26-013975.md) | [16.3%](/filings/0001437749-26-024943.md) | [10.3%](/filings/0001437749-26-033847.md) |
| Diluted EPS | $ per share | not reported | [0.19](/filings/0001437749-26-013975.md) | [0.13](/filings/0001437749-26-024943.md) | [0.40](/filings/0001437749-26-033847.md) | not reported | [0.32](/filings/0001437749-26-013975.md) | [0.68](/filings/0001437749-26-024943.md) | [0.48](/filings/0001437749-26-033847.md) |
| Free cash flow | $m | [11.7 d](/filings/0001437749-26-006094.md) | [3.2](/filings/0001437749-26-013975.md) | [12.9 d](/filings/0001437749-26-024943.md) | [(1.3) d](/filings/0001437749-26-033847.md) | [13.7 d](/filings/0001437749-26-006094.md) | [5.3](/filings/0001437749-26-013975.md) | [8.2 d](/filings/0001437749-26-024943.md) | [14.0 d](/filings/0001437749-26-033847.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-25) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [314](/filings/0001437749-24-010066.md) | [314](/filings/0001437749-24-010066.md) | [264](/filings/0001437749-25-006863.md) | [252](/filings/0001437749-26-006094.md) | [240](/filings/0001437749-26-006094.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.2%](/filings/0001437749-24-010066.md) | [8.4%](/filings/0001437749-24-010066.md) | [6.8%](/filings/0001437749-25-006863.md) | [8.0%](/filings/0001437749-26-006094.md) | [7.8%](/filings/0001437749-26-006094.md) |
| Net margin | % | [7.8%](/filings/0001437749-24-010066.md) | [5.7%](/filings/0001437749-24-010066.md) | [3.7%](/filings/0001437749-25-006863.md) | [5.2%](/filings/0001437749-26-006094.md) | [5.7%](/filings/0001437749-26-006094.md) |
| Diluted EPS | $ per share | [1.76](/filings/0001437749-24-010066.md) | [1.31](/filings/0001437749-24-010066.md) | [0.71](/filings/0001437749-25-006863.md) | [0.93](/filings/0001437749-26-006094.md) | [0.99](/filings/0001437749-26-006094.md) |
| Free cash flow | $m | [(8.6)](/filings/0001437749-24-010066.md) | [6.5](/filings/0001437749-24-010066.md) | [46.2](/filings/0001437749-25-006863.md) | [34.0](/filings/0001437749-26-006094.md) | [28.5](/filings/0001437749-26-006094.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/esca/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Minerva Advisors LLC](/funds/1541536.md) | 2026-06-30 | $10.7m | 567,222 |  | Reduced −399 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $9.9m | 524,543 |  | Reduced −15,238 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $8.7m | 461,298 |  | Added +5,509 |
| [North Star Investment Management Corp.](/funds/1342857.md) | 2026-06-30 | $7.9m | 420,345 |  | Reduced −2,000 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.7m | 358,589 |  | Reduced −39,348 |
| [Rehmann Capital Advisory Group](/funds/1633037.md) | 2026-06-30 | $5.8m | 309,213 |  | Unchanged |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.1m | 215,673 |  | Reduced −8,037 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.5m | 132,569 |  | Reduced −3,254 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $1.7m | 91,597 |  | Reduced −567 |
| [Mork Capital Management, LLC](/funds/1626494.md) | 2026-06-30 | $1.5m | 80,000 |  | Unchanged |

## Recent filings

[All 953 filings](/companies/esca/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 06:15 ET | [10-Q](/filings/0001437749-26-033847.md) | Quarterly report, period 2026-09-30 | 0001437749-26-033847 |
| 2026-10-29 | 06:05 ET | [8-K](/filings/0001437749-26-033842.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-033842 |
| 2026-08-25 | 06:01 ET | [8-K](/filings/0001437749-26-028877.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-028877 |
| 2026-07-30 | 06:31 ET | [10-Q](/filings/0001437749-26-024943.md) | Quarterly report, period 2026-06-30 | 0001437749-26-024943 |
| 2026-07-30 | 06:30 ET | [8-K](/filings/0001437749-26-024942.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024942 |
| 2026-05-05 | 16:03 ET | [8-K](/filings/0001437749-26-014869.md) | 5.07 Shareholder vote results | 0001437749-26-014869 |
| 2026-04-30 | 06:31 ET | [10-Q](/filings/0001437749-26-013975.md) | Quarterly report, period 2026-03-31 | 0001437749-26-013975 |
| 2026-04-30 | 06:30 ET | [8-K](/filings/0001437749-26-013974.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-013974 |
| 2026-04-15 | 16:30 ET | [SCHEDULE 13D](/filings/0001463197-26-000012.md) | Ownership report, active investor | 0001463197-26-000012 |
| 2026-03-27 | 07:30 ET | [DEF 14A](/filings/0001437749-26-009992.md) | Proxy statement, period 2026-05-05 | 0001437749-26-009992 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-006094.md), filed Feb 27, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/57af1b95-5097-4f1e-af8b-efafe6b5ae08)

## About the filer

- CIK: 33488
- Tickers: ESCA
- Exchange: Nasdaq
- SIC code: 3949 Sporting & Athletic Goods, NEC
- State of incorporation: IN
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 06:29 ET. No prices; not investment advice.
